Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study

Masao Yamaguchi1 Division of Respiratory Medicine, Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara, Chiba, JapanCorrespondence[email protected]

https://orcid.org/0000-0001-6167-0591 View further author information

Yoshihiro Nishimura2 Kita-Harima Medical Center, Ono, Hyogo, JapanView further author information

Yuko Takumi3 Patient Safety Division, Research and Development, AstraZeneca K.K., Osaka, JapanView further author information

Nobuya Hayashi4 Data Science and Innovation Division, Research and Development, AstraZeneca K.K., Osaka, Japan

https://orcid.org/0000-0002-5386-5599 View further author information

Kei Sakamoto3 Patient Safety Division, Research and Development, AstraZeneca K.K., Osaka, JapanView further author information

Yuji Tohda5 Department of Respiratory Medicine and Allergology, Kindai University School of Medicine, Osaka-Sayama, Osaka, JapanView further author information

Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date